Kinase activation and smooth muscle contraction in the presence and absence of calcium.
Kinase activation and smooth muscle contraction in the presence and absence of calcium.
复制标题
在钙存在和不存在的情况下激酶激活和平滑肌收缩。
DOI:
10.1016/s0741-5214(95)70086-2
复制
发表时间:
1995
影响因子:
4.3
通讯作者:
Brophy,C
中科院分区:
文献类型:
--
作者:
Whitney,G;Throckmorton,D;Isales,C;Takuwa,Y;Yeh,J;Rasmussen,H;Brophy,C
PurposeThe intracellular signalling mechanisms that modulate the sustained vascular smooth muscle contractions that occur with vasospasm are not well understood. The purpose of this investigation was to examine cell signalling mechanisms that account for sustained vascular smooth muscle contraction, independent of increases in intracellular Ca2+concentrations ([Ca2+]i).MethodsFresh bovine carotid artery smooth muscles contractile responses were examined in a muscle bath. [Ca2+]iwas depleted by use of the extracellular Ca2+chelator, ethylene glycol-bis(ß-aminoethylether) N, N, N′, N′-tetraacetic acid and the intracellular chelator, 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′,-tetraacetic acid.ResultsIn Ca2+-free conditions, depolarizing the membrane with high extracellular KCI failed to elicit a contraction. In addition, in Ca2+-free conditions the ([Ca2+]i) was less than 10 nmol/L as determined with the Ca2+-indicator, Fura 2. The protein kinase C (PKC) activator, phorbol 12, 13-dibutyrate (PDBu), induced slowly developing sustained contractions in bovine carotid artery smooth muscle, and the magnitude of the contractile response to PDBu (10 nmol/L to 10 μmol/L) was the same in the presence and absence of Ca2+. PDBu induced contractions in Ca2+-free conditions were not inhibited by the myosin light chain kinase inhibitor, ML-9 (50 μmol/L), but were inhibited by the PKC inhibitor, staurosporine (50 nmol/L).ConclusionsThese data suggest that vascular smooth muscle contractions can occur under conditions where the [Ca2+]iis low and fixed and that these contractions may be mediated by PKC. (J VASC SURG 1995;22:37-44.)
登录
查看更多内容
DOI:
--
发表时间:
1987
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
Gerthoffer,WT
通讯作者:
Gerthoffer,WT
DOI:
10.1016/s0021-9258(18)34459-4
发表时间:
1982-07
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
M. Castagna;Y. Takai;K. Kaibuchi;K. Sano;U. Kikkawa;Y. Nishizuka
通讯作者:
M. Castagna;Y. Takai;K. Kaibuchi;K. Sano;U. Kikkawa;Y. Nishizuka
DOI:
10.1016/s0021-9258(18)66923-6
发表时间:
1986-11
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
Y. Takuwa;N. Takuwa;H. Rasmussen
通讯作者:
Y. Takuwa;N. Takuwa;H. Rasmussen
影响因子:
20.1
作者:
Katsuyama,H;Morgan,KG
通讯作者:
Morgan,KG
DOI:
--
发表时间:
1985-03
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
G. Grynkiewicz;M. Poenie;Roger Y. TsienB
通讯作者:
G. Grynkiewicz;M. Poenie;Roger Y. TsienB